儿童医院毛细支气管炎住院患儿用药分析

Analysis of Drug Use in Hospitalized Children with Bronchiolitis

目的探讨住院毛细支气管炎患儿的治疗现状。方法回顾性分析2015年1月至2016年12月医院毛细支气管炎住院患儿的药物治疗情况,分析其支气管扩张剂、激素、抗菌药物及抗病毒药物的使用情况。结果共入选患儿358例,351例(98. 04%)使用了支气管扩张剂,其中30. 48%的患儿伴有过敏或哮喘史; 352例(98. 32%)使用了激素,其中仅26. 99%的患儿伴有哮喘史或湿疹史; 159例(44. 41%)使用抗菌药物,其中48. 43%的患儿伴有高危因素; 306例(85. 47%)使用抗病毒药物。结论支气管扩张剂、激素、抗菌药物、抗病毒药物在住院毛细支气管炎患儿中应用广泛,我国亟待出台相关指南规范毛细支气管炎的治疗。

Objective To investigate the current medication treatment of hospitalized children with bronchiolitis. Methods The medication treatment of the hospitalized children with bronchiolitis in our hospital from January 2015 to December 2016 were retrospectively analyzed. The medications including bronchodilators, corticosteroids, antibiotics and antiviral agents were analyzed. Results Totally 358 hospitalized children were included. Among them, 351（98.04% ） children received bronchodilators, of which 30.48% were associated with a history of allergies or asthma. Totally 352（98.32% ） children received corticosteroids, of which only 26.99% were associated with a history of asthma and eczema. Totally 159（44.41% ） children received antibiotics, of which 48.43% associated with high risk factors. Totally 306（85.47% ） children received antiviral drugs. Conclusion There is a wide spread use of bronchodilators, corticosteroids, antibiotics and antiviral agents in the treatment of bronchiolitis. It is urgent for our country to appear personally relevant guidelines to standardize the treatment of bronchiolitis.